DYADIC INTERNATIONAL INC 8K

Dyadic International regained compliance with Nasdaq listing rules 5550(a)(2) and 5550(b), securing the continued listing of its common stock on The Nasdaq Capital Market.

Dyadic International, Inc., doing business as Dyadic Applied BioSolutions, announced that The Nasdaq Capital Market has confirmed the company has regained compliance with Nasdaq Listing Rules 5550(a)(2) (minimum bid price) and 5550(b) (stockholders’ equity/market value/total assets and revenue requirements), and that its common stock will continue to be listed and traded on The Nasdaq Capital Market, resolving its prior continued listing issue and allowing management to refocus on executing its business strategy and expanding adoption of its C1 and Dapibus protein production platforms.

Filing Facts

CIK

1213809

Ticker

-

Form

8K

Source Type

sec

Accession

0001493152-26-034475

Alert Tier

6